MRUS - Merus N V Stock Trading

Merus N.V.(NASDAQ: MRUS) stock trading description contact officers and directors.

About Merus N.V.

Not available

Stock Information

Merus N.V. Company Name:

MRUS Stock Symbol:

NASDAQ Market:

Get MRUS Alerts

News, Short Squeeze, Breakout and More Instantly...

MRUS - Merus Presents Clinical Data on Zenocutuzumab (Zeno) in NRG1-fusion (NRG1+) Cancer at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting (Oral Abstract)

34% overall response rate in 79 evaluable patients with measurable disease 9.1 months median duration of response Tumor reduction in 70% of patients Zeno observed to be very well-tolerated Potential new standard of care for patients with NRG1+ cancer Investor call to d...
MRUS - Merus to Participate in a Fireside Chat at the Jefferies Healthcare Conference

UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 03, 2022 (GLOBE NEWSWIRE) -- Merus N.V . (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics ® and Triclonics ® ), today announced that Bill Lundber...
MRUS - Merus Announces Publication of Abstract of Zenocutuzumab in NRG1-fusion (NRG1+) Cancer at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

- Robust 34% overall response rate and 9.1 months median duration of response across multiple NRG1+ tumor types - Zenocutuzumab observed to be well-tolerated - Oral presentation with additional patient data at ASCO on June 5, 2022, 9:45 -11:15 a.m. CT - Investor call to discus...